THERAPY DOSSIER · th-fe2670be93f4

Copaiba oil

Nutraceutical · Botanical (copaiba oil); not a discrete ChEMBL entity

Evidence & regulatory context

Mechanism: Botanical (copaiba oil); not a discrete ChEMBL entity
Target: Not recorded
Injury models: Wound
Reported indication: Not recorded
First approval: Not recorded
Development stage: Not recorded
ChEMBL record: Not recorded
ChEMBL max phase: Not recorded
Synonyms: Not recorded
Note: Not recorded

Clinical trials 1

0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.

NCT06708702 ↗PHASE2withdrawn

Copaiba-based Mouthwash in Oral Mucositis Prevention and Treatment in Oral Cancer Patients

Oral Mucositis

Enrolment: 0 · Results not recorded

Preclinical evidence 1

1 studies reported at therapy level; 1 evidence entries itemised.

PMID 23370927 ↗2013Mixed findings

Effect of copaiba oil on correction of abdominal wall defect treated with the use of polypropylene/polyglecaprone mesh.

RatWoundn = 36 rats in 3 groupsOral gavage, or dip application onto the mesh

Model: Surgically created abdominal wall defect repaired with polypropylene/polyglecaprone mesh

Copaiba oil by gavage reduced abdominal adhesions and accelerated collagen fibre formation, whereas dip application directly onto the mesh had corrosive effects with greater necrosis and fibrosis than controls.

Extraction: extract · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.

Loading the evidence…